The PKD HTS assay was developed and run at the University of Pittsburgh Molecular Screening Center (PMLSC) as part of the Molecular Library Screening Center Network (MLSCN)(1R03DA24898-01). Protein kinase D (PKD) is a novel family of serine/threonine kinases targeted by diacylglycerol. It regulates many fundamental cell functions including cell proliferation, survival, differentiation and protein trafficking, and plays important roles in pathological conditions such as cardiac hypertrophy and cancer in multiple organ systems. However, the mechanisms underlying these effects of PKD are not clearly understood, and the role of PKD in cancer and other diseases has not been fully defined. This is partly due to the lack of effective pharmacological tools that specifically target PKD in normal cellular processes and in pathological conditions. The immediate goal of this proposal is to demonstrate the feasibility of an IMAP-based HTS fluorescent polarization (FP) assay and its use to identify novel PKD inhibitors. The assay we implemented is in a 384-well, small volume format and has been adapted for high throughput screening. Compounds identified in the primary screening activities were confirmed as PKD inhibitors by a 10-point dose response assay. The described IMAP-based HTS AKT assay was used as a counterscreen to determine the specificity of the identified PKD inhibitors from the 57K compound library addition (to the original 140K library that was previously screened). Protocol AKT counterscreening assay protocol for identified PKD inhibitors (384-well HTS) Reagents 1X kinase reaction buffer 10 mM Tris-HCl, pH 7.2 10 mM MgCl2 0.05% NaN3 0.1% Bovine serum albumin 1 mM DTT Substrate/ATP (3X concentration) 900 nM substrate peptide 30 uM ATP in 1X kinase reaction buffer Max control (3X concentration) 3% DMSO in 1X kinase reaction buffer Min control (3X concentration) 300 uM H-89 in 1X kinase reaction buffer IC50 control (3X concentration) 15 uM H-89 in 1X kinase reaction buffer Compounds (3X concentration) 2 uL of 1 mM compounds solubilized in 1X kinase reaction buffer starting at 300 uM (3X concentration) and subjected to a 2-fold serial dilution Enzyme (3X concentration) 0.15 mUnits/uL in 1X kinase reaction buffer Binding reagent 1:400 dilution binding reagent in 75% 1X binding buffer A and 25% 1X binding buffer B Assay Procedure (1)Prepare reagents as described above (2)Add 2 uL of a substrate peptide and ATP mixture to appropriate wells. (3)Add 2 uL of test compound dilution or controls to appropriate wells. (4)Add 2 uL of AKT1 enzyme to each well. (6)Incubate for 1.5 hours at room temperature. (7)Add 18 uL of Binding reagent to each well and incubate for 2 hours. (8)Collect data at A485/A525.
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000294 ; # "has participant" -> "kinase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0002005 ; # "is bioassay type of" -> "kinase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0002593 ; # "has assay method" -> "substrate coupled enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0002594 ; # "has assay method" -> "ATP coupled enzyme activity measurement method"
bao:BAO_0000207 bao:BAO_0000003 ; # "has detection method" -> "fluorescence polarization"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Inhibitors of the Protein Kinase D1 (PKD)" ; # "screening campaign name" -> "Inhibitors of the Protein Kinase D1 (PKD)"
bao:BAO_0002853 "AKT counterscreen of confirmed PKD inhibitors-57K library" ; # "has assay title" -> "AKT counterscreen of confirmed PKD inhibitors-57K library"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002867 bao:BAO_0000515 ; # "has assay footprint" -> "384 well plate"
bao:BAO_0002863 bao:BAO_0000535 ; # "has concentration throughput" -> "multiple concentration"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "90 minute" ; # "has incubation time value" -> "90 minute"
bao:BAO_0002857 "DMSO 3% in 1x kinase reaction buffer" ; # "has signal direction" -> "DMSO 3% in 1x kinase reaction buffer"
bao:BAO_0000740 bao:BAO_0000156 ; # "has assay control" -> "high signal control"
bao:BAO_0002857 "H-89 (PKA inhibitor)" ; # "has signal direction" -> "H-89 (PKA inhibitor)"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000694 ; # "has participant" -> "Tris" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0000895 ; # "has participant" -> "DTT" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_63247> ; # "has role" -> "reducing agent"
bao:BA0_0090012 "RAC-alpha serine/threonine-protein kinase" ; # "has participant" -> "RAC-alpha serine/threonine-protein kinase"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P31749" ; # "uniprot ID" -> "P31749"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
bao:BAO_0002922 "\"10 mM Tris-HCl pH 7.2, 10 mM MgCl2, 0.05% NaN3, 0.1% BSA, 1 mM DTT\"" ; # "has assay medium" -> ""10 mM Tris-HCl pH 7.2, 10 mM MgCl2, 0.05% NaN3, 0.1% BSA, 1 mM DTT""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "0.1% bovine serum albumin" ; # "material entity assay serum" -> "0.1% bovine serum albumin"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000325 ; # "has participant" -> "peptide"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 "immobilized metal affinity for phosphochemicals (IMAP)-based fluorescence polarization" ; # "uses detection instrument" -> "immobilized metal affinity for phosphochemicals (IMAP)-based fluorescence polarization"
bao:BAO_0002917 "485 nanometer" ; # "has excitation wavelength value" -> "485 nanometer"
bao:BAO_0002918 "525 nanometer" ; # "has emission wavelength value" -> "525 nanometer"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0002787 "10" ; # "has concentration-point number" -> "10"
bao:BAO_0002845 "3" ; # "has repetition point-number" -> "3"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
